Latest Headlines

  1. Thermo Fisher Scientific Launches Collection Kit To Streamline Saliva Testing 6/29/2021

    As businesses, universities and schools reopen, SARS-CoV-2 virus surveillance is critical to the management of outbreaks and emerging new strains, including the Delta variant that now makes up 91 percent of new cases in the United Kingdom. To support large-scale research and surveillance programs, Thermo Fisher Scientific today introduced the Thermo Scientific SpeciMAX Saliva Collection Kit.

  2. Inova Diagnostics Announces FDA 510(k) Clearance For Aptiva®, A Digital Multi-Analyte System 6/29/2021

    Inova Diagnostics, a worldwide leader in IVD systems and reagents for autoimmune disease in the clinical laboratory, is pleased to announce FDA 510(k) clearance of its Aptiva® System and Aptiva® Celiac Disease IgA assay. Aptiva is a fully automated digital multi-analyte system that represents the next generation of high-throughput processors for the clinical laboratory. CE (Conformité Européenne) Marking for Aptiva was received in August of 2020.

  3. Eurofins To Acquire DNA Diagnostics Center To Grow Genetic Testing Capabilities And Significantly Expand Further Into Consumer Testing Market 6/28/2021

    Eurofins Scientific (“Eurofins”), a global scientific leader in bioanalytical testing, announces that its subsidiary Eurofins Clinical Testing US Holdings, Inc. has entered into an agreement to acquire DNA Diagnostics Center (“DDC”), a leader in consumer genetic testing. DDC anticipates delivering revenues of over US$55m in 2021.

  4. Test Distinguishes SARS-CoV-2 From Other Coronaviruses With 100% Accuracy 6/25/2021

    Biomedical engineers at Duke University have demonstrated a tablet-sized device that can reliably detect multiple COVID-19 antibodies and biomarkers simultaneously.

  5. New Sale Of LexaGene’s MiQLab™ System Propels Early Diagnostic Testing In Veterinarian Practices 6/24/2021

    LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced Meridian Veterinary Capital, LLC (“Meridian”) has purchased a MiQLab System to be used by the emergency and specialty veterinary hospitals they support with locations across the country.

  6. Natera And BGI Genomics Announce Commercial Launch Of The BGI/Natera Signatera Assay In China 6/24/2021

    Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, and BGI Genomics Co., Ltd., (300676.SZ), one of the world's leading genomics companies, today announced the launch of the BGI/Natera Signatera Assay which is now available to biopharmaceutical customers and clinicians across China.

  7. The Launch Of U-Load Dextramer With Peptide Receptive MHC I And MHC II Monomers Greatly Expands Flexibility While Ensuring Reliable Sensitivity In Exploring Diversity Of Cellular Immune Responses 6/24/2021

    Immudex announces the launch of the new U-Load Dextramer product line that allows scientists to swiftly assemble their own sensitive antigen-specific Dextramer reagents for immune monitoring directly in the lab using loadable MHC class I easYmer and the novel loadable MHC class II monomers, U-Load MHC II.

  8. Infinity BiologiX And Cytox Collaborate To Provide New Genetic Test To Predict The Risk Of Cognitive Decline Due To Alzheimer’s Disease 6/23/2021

    Today, Infinity BiologiX, LLC (IBX) and Cytox Ltd, announce a collaboration to provide a new, non-invasive, genetic test that can predict the risk of cognitive decline due to Alzheimer’s through a simple saliva or blood sample.

  9. CS Analytical Laboratory Completes Installation Of Lighthouse Instruments Suite Of Laser Based Headspace Capabilities For Container Closure Integrity Testing 6/23/2021

    CS Analytical Laboratory, the world’s only cGMP, FDA-registered and inspected contract laboratory exclusively designed and dedicated to container testing for the pharmaceutical, biotechnology, and medical device industries, is pleased to announce that it has completed the installation and cGMP qualification process for its suite of laser-based headspace analysis systems in support of the USP〈1207〉Container Integrity Testing service platform.

  10. Dante Labs Acquires Cambridge Cancer Genomics To Create Global Excellence In Precision Oncology 6/23/2021

    Dante Labs, a leading genomics and diagnostics company, today announced the acquisition of Cambridge Cancer Genomics (CCG.ai), a groundbreaking Y-Combinator company & leader in machine learning for clinical oncology, to create a single platform with unparalleled capabilities in genomics and oncology data analysis.